About Cncbd
Cncbd is a Healthcare company based in China. Biotechnology research and development are facilitated in China. Cncbd offers products and services including Biotechnology Research and Policy and Collaboration Services. Its focus areas include Medical Research Labs. Its legal entity in India is δΈε½ηη©ζζ―εε±δΈεΏ (U99999MH1977PLC010754).
Company details
Operations are centered in China within the biotechnology sector. Research, development, and collaboration in biopharmaceuticals are supported through information dissemination on technological advancements. Conferences and competitions are organized, while collaborative projects are promoted. Growth in the industry is fostered via initiatives and announcements, contributing to scientific knowledge and innovation. Services extend to resource provision for biotechnical efforts.
- Headquarters China
- SectorsHealthcare
- Website cncbd.org.cn
- Legal Name 中国生物技术发展中心
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Investors
Associated legal entities of Cncbd
Cncbd operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Cncbd
Cncbd offers a comprehensive portfolio of products and services, including Biotechnology Research and Policy and Collaboration Services.
Research in biotechnology fields is conducted to advance scientific knowledge and innovations
Policies for biotechnology development are formulated and international cooperations are managed to support related initiatives
Funding Insights of Cncbd
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Cncbd with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in Cncbd
Cncbd has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Cncbd
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Cncbd
The website of Cncbd (cncbd.org.cn) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 316.9% vs previous month
Websites whose visitors overlap most with Cncbd. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| siat.cas.cn | 60% | 54.3K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cncbd
Complete news archive for Cncbd
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cncbd
Cncbd is headquartered in China.
Operations are centered in China within the biotechnology sector. Research, development, and collaboration in biopharmaceuticals are supported through information dissemination on technological advancements. Conferences and competitions are organized, while collaborative projects are promoted. Growth in the industry is fostered via initiatives and announcements, contributing to scientific knowledge and innovation. Services extend to resource provision for biotechnical efforts.
Cncbd offers Biotechnology Research and Policy and Collaboration Services.
Cncbd has 1 investor. Key investors include European Union.
Cncbd operates through ,.